[BSX] Boston Scientific Corporation

Overview

Type of security: Stock

Sector: Health Care

Industry: Medical/Dental Instruments

Market Capitalization:

Exchange: NYSE

The data is delayed by 15 minutes.

 

Price: 21.81 Change: 0.15 (0.69%)
Ext. hours: Change: 0 (0%)

chart BSX

Refresh chart

Strongest Trends Summary For BSX

BSX is in the medium-term down -10% below S&P in 2 months. In the long-term up 18% above S&P in 2 years and up 355% in 9 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in three segments: Cardiovascular, Rhythm Management, and MedSurg. It offers interventional cardiology products, including coronary stent systems used in the treatment of coronary artery disease; coronary technology products used to treat patients with atherosclerosis; intraluminal catheter-directed ultrasound imaging catheters and systems for use in coronary arteries and heart chambers, as well as peripheral vessels; and structural heart therapy systems. The company also provides stents, balloon catheters, wires, peripheral embolization devices, and vena cava filters to treat patients with peripheral disease; and biliary stents, drainage catheters, and micro-puncture sets to treat patients with non-vascular disease. In addition, it offers cardiac rhythm management devices, such as implantable cardioverter defibrillator systems to detect and tr

Fundamental Ratios
Shares Outstanding EPS0.73 EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters -5.61% Sales Growth - Q/Q-6.31% P/E38.01
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA-1.54% ROE-3.89% ROI-1.94%
Current Ratio1.29 Quick Ratio0.91 Long Term Debt/Equity5.3 Debt Ratio0.38
Gross Margin70.26% Operating Margin-6.43% Net Profit Margin-3.43% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities-94 M Cash From Investing Activities-51 M Cash From Operating Activities-197 M Gross Profit1.3 B
Net Profit102 M Operating Profit219 M Total Assets17.12 B Total Current Assets3.77 B
Total Current Liabilities1.94 B Total Debt5.11 B Total Liabilities10.54 B Total Revenue1.84 B
Technical Data
High 52 week43.45 Low 52 week31.73 Last close38.46 Last change1.29%
RSI32.22 Average true range1.16 Beta0.9 Volume4.25 M
Simple moving average 20 days-4.97% Simple moving average 50 days-7.45% Simple moving average 200 days-2.99%
Performance Data
Performance Week1.56% Performance Month-8.3% Performance Quart-8.95% Performance Half6.33%
Performance Year3.97% Performance Year-to-date8.83% Volatility daily2.11% Volatility weekly4.71%
Volatility monthly9.65% Volatility yearly33.42% Relative Volume246.39% Average Volume6.14 M
New High New Low

News

2019-11-16 15:54:35 | UPDATE 1-Stents no better than drugs for many heart patients -U.S. study

2019-11-16 14:00:00 | Stents no better than drugs for many heart patients -U.S. study

2019-11-13 13:50:39 | Large Option Traders Betting Boston Scientific Has Run Out Of Steam

2019-11-12 16:30:00 | Boston Scientific Completes €900 million Offering of Senior Notes and $1.0 billion Tender Offer

2019-11-10 08:00:24 | How Good Is Boston Scientific Corporation NYSE:BSX, When It Comes To ROE?

2019-11-08 12:15:00 | 78 Stocks in the S&P 500 Don’t Pay a Dividend. Here Are Some That Should.

2019-11-06 18:30:00 | Boston Scientific Prices €900,000,000 of Senior Notes

2019-11-06 09:06:09 | Boston Scientific Corporation -- Moody's assigns Baa2 rating to Boston Scientific's euro note offering

2019-11-05 19:39:00 | Boston Scientific Announces Pricing Terms of Its Cash Tender Offer for up to $1.0 Billion of Its Outstanding Debt Securities

2019-11-05 13:13:00 | Boston Scientific Announces Positive Data for the Ranger™ Drug-Coated Balloon and the Eluvia™ Drug-Eluting Vascular Stent at VIVA19

2019-11-05 11:01:55 | Which Companies Recently Raised Guidance?

2019-11-05 06:30:00 | Boston Scientific Announces Early Results of Its Cash Tender Offer for up to $1.0 Billion of Its Outstanding Debt Securities

2019-11-01 09:30:00 | Boston Scientific Announces November 2019 Conference Schedule

2019-10-24 09:47:01 | Boston Scientific BSX Catches Eye: Stock Jumps 5%

2019-10-24 09:31:01 | Company News For Oct 24, 2019

2019-10-23 22:45:14 | Edited Transcript of BSX earnings conference call or presentation 23-Oct-19 12:00pm GMT

2019-10-23 16:04:04 | These Medtech Giants Are Nearing Breakouts After Earnings 'Crushed' It

2019-10-23 13:02:00 | Boeing, Caterpillar report disappointing earnings, but their shares bounce back

2019-10-23 10:37:00 | Boston Scientific Stock Gains on Strong Earnings

2019-10-23 09:49:01 | Boston Scientific BSX Beats on Q3 Earnings, Tapers EPS View

2019-10-23 09:10:00 | Boston Scientific Shares Rise on Third-Quarter Earnings Beat, Increased Guidance

2019-10-23 07:45:11 | Boston Scientific BSX Q3 Earnings and Revenues Beat Estimates

2019-10-23 06:58:00 | Boston Scientific's stock surges after profit and sales rise, beat expectations

2019-10-23 06:30:00 | Boston Scientific Announces Results For Third Quarter 2019

2019-10-22 14:49:00 | [video]Boston Scientific Expected to Earn 38 Cents a Share

2019-10-22 13:13:08 | Boston Scientific Corporation -- Moody's says Boston Scientific's bond tender is credit positive, no rating impact

2019-10-22 11:25:03 | Medical Products' Earnings Roster for Oct 23: TMO, BSX & More

2019-10-22 09:13:01 | Medical Products Industry Outlook: Prospects Seem Promising

2019-10-22 06:00:00 | Boston Scientific Announces Cash Tender Offer for Up To $1.0 Billion of Its Outstanding Debt Securities

2019-10-21 11:35:03 | Can Overall Growth Boost Boston Scientific BSX Q3 Earnings?

2019-10-18 07:03:18 | Is Boston Scientific's NYSE:BSX Share Price Gain Of 200% Well Earned?

2019-10-16 10:32:02 | Boston Scientific BSX Earnings Expected to Grow: Should You Buy?

2019-10-15 20:43:16 | Newton-Wellesley Hospital CEO steps down to join Boston Scientific

2019-10-09 10:36:55 | Hedge Funds Have Never Been This Bullish On Boston Scientific Corporation BSX

2019-10-02 09:48:01 | Abbott ABT Gets FDA Nod for New Troponin-I Blood Test

2019-10-02 09:25:01 | Abiomed's ABMD Impella 5.5 With SmartAssist Gets FDA Nod

2019-10-02 09:23:01 | Medtronic Upbeat on Drug-Eluting Stents in Patients With DAPT

2019-10-01 09:30:01 | PETQ vs. BSX: Which Stock Is the Better Value Option?

2019-10-01 09:30:00 | Boston Scientific Announces Conference Call Discussing Third Quarter 2019 Financial Results

2019-09-30 08:59:12 | Boston Scientific BSX Upbeat on Results of EVOLVE Study

2019-09-29 10:59:29 | 8 'Low Beta' Growth Stocks That Can Lead Amid Market's Turmoil

2019-09-26 15:15:00 | Boston Scientific Announces Positive Data from the EVOLVE Short DAPT study with the SYNERGY™ Bioabsorbable Polymer Stent

2019-09-26 07:33:17 | 3 “Strong Buy” Med Tech Stocks Amid Recession Threat

2019-09-25 10:38:59 | Boston Scientific Corporation NYSE:BSX Insiders Have Been Selling

2019-09-19 09:35:00 | 10 Stable Growth Stocks That Are Still Worth the Price, According to an Analyst

2019-09-18 06:45:00 | Boston Scientific Announces Scheduled Presentations at Transcatheter Cardiovascular Therapeutics 2019

2019-09-13 09:40:01 | BAX or BSX: Which Is the Better Value Stock Right Now?

2019-09-13 09:13:01 | IoMT Becomes the Buzzword in New Age MedTech Investing

2019-09-10 11:07:35 | Morgan Stanley: Buy These 3 Stocks on Recent Weakness

2019-09-10 07:13:25 | 3 Big Stock Charts for Tuesday: Boston Scientific, GM and United Airlines